FDA inspection
Neos Therapeutics, LP: FDA inspection ending Sep 7, 2018
FDA inspection 1067923 · No Action Indicated (NAI) · Grand Prairie, TX
Key facts
| Inspection ID | 1067923 |
|---|---|
| Firm | Neos Therapeutics, LP |
| FEI number | 3000205839 |
| Address | 2940 N Hwy 360 Ste 100 |
| City | Grand Prairie |
| State | TX |
| ZIP | 75050 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Sep 7, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data